Voss Capital LP 13D/13G Filings for Actuate Therapeutics Inc (ACTU)

Voss Capital LP 13D and 13G filings for Actuate Therapeutics Inc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-12-17
12:25 pm
Purchase
2025-12-1513GActuate Therapeutics Inc
ACTU
Voss Capital LP1,227,756
5.300%
1,227,756increase
(New Position)
Filing